Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-8.58 M USD-16.32 M USD-757000 USD-1.85 M USD8.13 M USD-14.87 M USD-1.32 M USD-3.35 M USD-3.58 M USD-5.72 M USD-4.13 M USD-4.38 M USD
Depreciation & Amortization27.71 M USD30.76 M USD27.49 M USD22.77 M USD20.25 M USD9.87 M USD2.42 M USD857939 USD664831 USD374202 USD197938 USD311590 USD
Stock-Based Compensation10.07 M USD19.70 M USD22.81 M USD20.08 M USD15.35 M USD8916 USD16.52 M USD5.48 M USD3.55 M USD3.12 M USD881706 USD678119 USD
Capital Expenditures16.44 M USD17.25 M USD38.78 M USD22.11 M USD23.88 M USD8.92 M USD5.34 M USD2.91 M USD1.71 M USD1.06 M USD70130 USD138886 USD
Cash Flow from Investing250.32 M USD176.81 M USD36.05 M USD-59.68 M USD-469.25 M USD-382.31 M USD-62.93 M USD-12.88 M USD-1.80 M USD-1.07 M USD-70130 USD-138886 USD
Cash Flow from Financing-21.07 M USD-161.53 M USD-23.80 M USD-39.17 M USD564.34 M USD385.58 M USD74.15 M USD38.53 M USD15.90 M USD6.06 M USD5.23 M USD4.33 M USD
Dividends Paid
Stock Buybacks10.01 M USD37.96 M USD0 USD0 USD
Free Cash Flow-25.02 M USD-33.58 M USD-39.54 M USD-23.96 M USD-15.76 M USD-23.78 M USD-6.66 M USD-6.27 M USD-5.30 M USD-6.78 M USD-4.20 M USD-4.52 M USD

Cryoport Inc. is a global provider specializing in temperature-controlled logistics solutions for the life sciences industry. Its primary function is to ensure safe and efficient transportation of temperature-sensitive materials, including biological samples, pharmaceuticals, and other life sciences products. Notable for its comprehensive solutions, Cryoport offers a range of services including cryogenic transportation, monitoring, and logistics management, which are vital for maintaining product integrity and regulatory compliance. The company's offerings significantly impact sectors such as biotechnology, pharmaceuticals, and medical research, where precision and reliability are crucial. Cryoport's logistic services support the entire lifecycle of biopharmaceuticals, from research and development to clinical trials and commercialization. Cryoport's role in the financial market is underscored by its contribution to sustaining critical supply chains in the rapidly growing life sciences sector, making it a cornerstone for companies that rely on precise and secure logistics for their valuable materials. Headquartered in Nashville, Tennessee, Cryoport's innovation and commitment to quality make it a key player in enhancing the global capabilities of temperature-controlled logistic solutions for sensitive biological materials.